# Tissue Analytics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tissue-analytics

- Industry: Healthcare IT
- Headquarters: Baltimore, US
- Website: www.tissue-analytics.com
- Total disclosed funding: $5.8M
- Latest round: Series A (Jan 16, 2018)
- Investors on record: 6

## About

Tissue Analytics, Inc. is a provider of an advanced wound imaging and care analytics platform that leverages Artificial Intelligence (AI) to improve wound assessment accuracy and streamline healthcare workflows.Founded in 2014 and headquartered in Baltimore, US, Tissue Analytics, Inc. specializes in advanced wound care solutions. The company was acquired by Net Health Systems, Inc. in May 2020, which is a part of Carlyle Group's portfolio. The founder, Gabriel Brat, has a history in healthcare technology, although specific details about previous ventures are unavailable. Tissue Analytics has engaged in five investment deals, with its most recent funding round being a Series A in 2020, raising USD 5.00 mn led by DigiTx Partners, along with other notable investors.Tissue Analytics offers a cutting-edge wound imaging and care analytics platform that utilizes Artificial Intelligence and machine learning to enhance wound assessments. The solution integrates with major electronic health record (EHR) systems, allowing healthcare practitioners in various environments, including hospitals and home healthcare, to effectively measure and document wounds. The platform has been widely adopted across over 25,000 healthcare facilities in the U.S. and is recognized internationally for its role in reducing hospital-acquired pressure injuries and improving patient management.Tissue Analytics generates revenue through a subscription-based model for its platform, catering to healthcare providers in need of advanced wound management solutions. Each subscription includes mobile wound imaging features, ongoing software updates, and customer support, creating a consistent income stream through annual renewals. The pricing model is designed for flexibility, accommodating the various needs of healthcare institutions and enhancing the quality of patient care while reducing the costs associated with wound management.Looking ahead, Tissue Analytics aims to expand its product offerings with new features and enhancements scheduled for release in late 2023. The company is focused on entering international markets, particularly targeting regions in Europe and Asia by 2024. The recent Series A funding round will be utilized to support these growth initiatives, enabling the development of advanced analytics capabilities and facilitating market entry strategies.

## Funding rounds

- Series A, Jan 16, 2018, $5M — Mölnlycke Health Care AB, Tencent Investment, DreamIt Ventures, Penn Medicine, DigiTx Partners, Intermountain Healthcare, Inc.
- Seed, May 18, 2015, $0.8M — Tencent Investment, DreamIt Ventures

## Investors

- Tencent Investment — Seed, Series A
- DreamIt Ventures (https://capitalatlas.ai/funds/dreamit-ventures) — Seed, Series A
- Mölnlycke Health Care AB — Series A
- Penn Medicine — Series A
- DigiTx Partners (https://capitalatlas.ai/funds/digitx-partners) — Series A
- Intermountain Healthcare, Inc. — Series A